Sammlung kostbarer Gemälde alter und moderner Meister : Versteigerung Montag, den 29. Mai 1922 ... / Hugo Helbing, München u. Frankfurt ; F. A. C. Prestel in Frankfurt am Main

Nebent.: Gemälde alter und moderner Meister Serie: Versteigerung / F. A. C. Prestel, Frankfurt am Main; [86

Electron interactions and charge ordering in La2−x_{2-x}Srx_xCuO4_4

We present results of inelastic light scattering experiments on single-crystalline La$_{2-x}$Sr$_{x}$CuO$_4$ in the doping range $0.00 \le x=p \le 0.30$ and Tl$_2$Ba$_2$CuO$_{6+\delta}$ at $p=0.20$ and $p=0.24$. The main emphasis is placed on the response of electronic excitations in the antiferromagnetic phase, in the pseudogap range, in the superconducting state, and in the essentially normal metallic state at $x \ge 0.26$, where no superconductivity could be observed. In most of the cases we compare B$_{1g}$ and B$_{2g}$ spectra which project out electronic properties close to $(\pi,0)$ and $(\pi/2, \pi/2)$, respectively. In the channel of electron-hole excitations we find universal behavior in B$_{2g}$ symmetry as long as the material exhibits superconductivity at low temperature. In contrast, there is a strong doping dependence in B$_{1g}$ symmetry: (i) In the doping range $0.20 \le p \le 0.25$ we observe rapid changes of shape and temperature dependence of the spectra. (ii) In La$_{2-x}$Sr$_{x}$CuO$_4$ new structures appear for $x < 0.13$ which are superposed on the electron-hole continuum. The temperature dependence as well as model calculations support an interpretation in terms of charge-ordering fluctuations. For $x \le 0.05$ the response from fluctuations disappears at B$_{1g}$ and appears at B$_{2g}$ symmetry in full agreement with the orientation change of stripes found by neutron scattering. While, with a grain of salt, the particle-hole continuum is universal for all cuprates the response from fluctuating charge order in the range $0.05 \le p < 0.16$ is so far found only in La$_{2-x}$Sr$_{x}$CuO$_4$. We conclude that La$_{2-x}$Sr$_{x}$CuO$_4$ is close to static charge order and, for this reason, may have a suppressed $T_c$.Comment: 17 pages, 15 figure

Quantum utility -- definition and assessment of a practical quantum advantage

Several benchmarks have been proposed to holistically measure quantum computing performance. While some have focused on the end user's perspective (e.g., in application-oriented benchmarks), the real industrial value taking into account the physical footprint of the quantum processor are not discussed. Different use-cases come with different requirements for size, weight, power consumption, or data privacy while demanding to surpass certain thresholds of fidelity, speed, problem size, or precision. This paper aims to incorporate these characteristics into a concept coined quantum utility, which demonstrates the effectiveness and practicality of quantum computers for various applications where quantum advantage -- defined as either being faster, more accurate, or demanding less energy -- is achieved over a classical machine of similar size, weight, and cost. To successively pursue quantum utility, a level-based classification scheme -- constituted as application readiness levels (ARLs) -- as well as extended classification labels are introduced. These are demonstratively applied to different quantum applications from the fields of quantum chemistry, quantum simulation, quantum machine learning, and data analysis followed by a brief discussion

Tenofovir Nephrotoxicity: 2011 Update

Tenofovir is an acyclic nucleotide analogue reverse-transcriptase inhibitor structurally similar to the nephrotoxic drugs adefovir and cidofovir. Tenofovir is widely used to treat HIV infection and approved for treatment of hepatitis B virus. Despite initial cell culture and clinical trials results supporting the renal safety of tenofovir, its clinical use is associated with a low, albeit significant, risk of kidney injury. Proximal tubular cell secretion of tenofovir explains the accumulation of the drug in these mitochondria-rich cells. Tenofovir nephrotoxicity is characterized by proximal tubular cell dysfunction that may be associated with acute kidney injury or chronic kidney disease. Withdrawal of the drug leads to improvement of analytical parameters that may be partial. Understanding the risk factors for nephrotoxicity and regular monitoring of proximal tubular dysfunction and serum creatinine in high-risk patients is required to minimize nephrotoxicity. Newer, structurally similar molecular derivatives that do not accumulate in proximal tubules are under study

Gap structure in the electron-doped Iron-Arsenide Superconductor Ba(Fe0.92Co0.08)2As2: low-temperature specific heat study

We report the field and temperature dependence of the low-temperature specific heat down to 400 mK and in magnetic fields up to 9 T of the electron-doped Ba(Fe0.92Co0.08)2As2 superconductor. Using the phonon specific heat obtained from pure BaFe2As2 we find the normal state Sommerfeld coefficient to be 18 mJ/mol.K^2 and a condensation energy of 1.27 J/mol. The temperature dependence of the electronic specific heat clearly indicate the presence of the low-energy excitations in the system. The magnetic field variation of field-induced specific heat cannot be described by single clean s- or d-wave models. Rather, the data require an anisotropic gap scenario which may or may not have nodes. We discuss the implications of these results.Comment: New Journal of Physics in press, 10 pages, 5 figure

Fibrillar Aβ (beta) triggers microglial proteome alterations and dysfunction in Alzheimer mouse models

Microglial dysfunction is a key pathological feature of Alzheimer's disease (AD), but little is known about proteome-wide changes in microglia during the course of AD and their functional consequences. Here, we performed an in-depth and time-resolved proteomic characterization of microglia in two mouse models of amyloid beta (A beta) pathology, the overexpression APPPS1 and the knock-in APP-NL-G-F (APP-KI) model. We identified a large panel of Microglial A beta Response Proteins (MARPs) that reflect heterogeneity of microglial alterations during early, middle and advanced stages of A beta deposition and occur earlier in the APPPS1 mice. Strikingly, the kinetic differences in proteomic profiles correlated with the presence of fibrillar A beta, rather than dystrophic neurites, suggesting that fibrillar A beta may trigger the AD-associated microglial phenotype and the observed functional decline. The identified microglial proteomic fingerprints of AD provide a valuable resource for functional studies of novel molecular targets and potential biomarkers for monitoring AD progression or therapeutic efficacy